Position in ENLV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$119,218
-$101,262 QoQ
Shares Held
128,192
-59.1% QoQ
Ownership
0.762%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENLV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. ENLV ranks #290 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in ENLV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $119,218 | 128,192 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $220,480 | 313,628 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $163,583 | 157,292 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $188,599 | 168,392 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $175,850 | 181,289 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $186,020 | 158,992 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $125,645 | 74,789 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $101,798 | 71,689 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $264,879 | 69,889 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $167,640 | 62,089 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $93,044 | 58,889 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $148,922 | 56,689 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $199,067 | 54,689 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $213,396 | 54,189 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $250,278 | 58,889 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $290,134 | 64,189 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $356,021 | 63,689 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $423,056 | 67,689 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $869,331 | 87,989 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,741,783 | 195,706 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,220,602 | 290,406 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,352,863 | 279,106 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,773,125 | 298,506 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,374,832 | 271,706 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $444,553 | 94,990 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||